Ipsen To File Cabozantinib For Liver Cancer In 1H 2018

 
• By Lucie Ellis-Taitt
  
Cirrhosis
Ipsen to file cabozantinib for liver cancer in Europe after Positive Phase III

More from Anticancer

More from Therapy Areas